The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/F8CB7AB3.svg?ark=w1%2F20260515%2FF8CB7AB3)](https://nobleid.org/work/w1/20260515/F8CB7AB3)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors